产品: | PKR 抗体 |
货号: | AF6801 |
描述: | Rabbit polyclonal antibody to PKR |
应用: | ELISA(peptide) |
反应: | Human |
分子量: | 65~75kD; 62kD(Calculated). |
蛋白号: | P19525 |
RRID: | AB_2847524 |
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF6801, RRID:AB_2847524.
展开/折叠
Double stranded RNA activated protein kinase;; E2AK2_HUMAN; eIF-2A protein kinase 2; EIF2AK1; EIF2AK2; Eukaryotic translation initiation factor 2 alpha kinase 2; Eukaryotic translation initiation factor 2-alpha kinase 2; HGNC:9437; Interferon induced double stranded RNA activated protein kinase; Interferon inducible elF2 alpha kinase; Interferon inducible RNA dependent protein kinase; Interferon-induced, double-stranded RNA-activated protein kinase; Interferon-inducible RNA-dependent protein kinase; MGC126524; P1/eIF-2A protein kinase; P1/eIF2A protein kinase; p68 kinase; PKR; PPP1R83; PRKR; Protein kinase interferon inducible double stranded RNA dependent; Protein kinase RNA activated; Protein kinase RNA-activated; Protein phosphatase 1 regulatory subunit 83; Serine/threonine protein kinase TIK; Tyrosine protein kinase EIF2AK2;
抗原和靶标
A synthesized peptide derived from human PKR.
Highly expressed in thymus, spleen and bone marrow compared to non-hematopoietic tissues such as small intestine, liver, or kidney tissues. Colocalizes with GSK3B and TAU in the Alzheimer disease (AD) brain. Elevated levels seen in breast and colon carcinomas, and which correlates with tumor progression and invasiveness or risk of progression.
- P19525 E2AK2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAGDLSAGFFMEELNTYRQKQGVVLKYQELPNSGPPHDRRFTFQVIIDGREFPEGEGRSKKEAKNAAAKLAVEILNKEKKAVSPLLLTTTNSSEGLSMGNYIGLINRIAQKKRLTVNYEQCASGVHGPEGFHYKCKMGQKEYSIGTGSTKQEAKQLAAKLAYLQILSEETSVKSDYLSSGSFATTCESQSNSLVTSTLASESSSEGDFSADTSEINSNSDSLNSSSLLMNGLRNNQRKAKRSLAPRFDLPDMKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC
翻译修饰 - P19525 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
S6 | Phosphorylation | Uniprot | |
K20 | Ubiquitination | Uniprot | |
S33 | Phosphorylation | Uniprot | |
K61 | Methylation | Uniprot | |
K69 | Methylation | Uniprot | |
K69 | Ubiquitination | Uniprot | |
K77 | Ubiquitination | Uniprot | |
K80 | Ubiquitination | Uniprot | |
S83 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
T88 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
T89 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
T90 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
S92 | Phosphorylation | Uniprot | |
S93 | Phosphorylation | Uniprot | |
Y101 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
K140 | Ubiquitination | Uniprot | |
Y142 | Phosphorylation | Uniprot | |
K150 | Ubiquitination | Uniprot | |
K159 | Ubiquitination | Uniprot | |
Y162 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
S179 | Phosphorylation | Uniprot | |
S181 | Phosphorylation | Uniprot | |
S242 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
K253 | Ubiquitination | Uniprot | |
T255 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
Y257 | Phosphorylation | Uniprot | |
T258 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
K268 | Ubiquitination | Uniprot | |
Y293 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
K299 | Ubiquitination | Uniprot | |
K304 | Ubiquitination | Uniprot | |
K380 | Ubiquitination | Uniprot | |
K385 | Ubiquitination | Uniprot | |
K388 | Ubiquitination | Uniprot | |
K400 | Ubiquitination | Uniprot | |
S407 | Phosphorylation | Uniprot | |
K408 | Ubiquitination | Uniprot | |
K416 | Ubiquitination | Uniprot | |
K426 | Ubiquitination | Uniprot | |
K429 | Ubiquitination | Uniprot | |
T437 | Phosphorylation | Uniprot | |
S438 | Phosphorylation | Uniprot | |
K440 | Ubiquitination | Uniprot | |
K444 | Ubiquitination | Uniprot | |
T446 | Phosphorylation | P19525 (EIF2AK2) | Uniprot |
T451 | Phosphorylation | P51812 (RPS6KA3) , P28482 (MAPK1) , P19525 (EIF2AK2) , Q16539 (MAPK14) | Uniprot |
Y454 | Phosphorylation | Uniprot | |
S456 | Phosphorylation | Uniprot | |
K509 | Ubiquitination | Uniprot | |
K512 | Ubiquitination | Uniprot | |
K517 | Ubiquitination | Uniprot | |
K521 | Ubiquitination | Uniprot | |
K522 | Ubiquitination | Uniprot | |
R534 | Methylation | Uniprot | |
T535 | Phosphorylation | Uniprot | |
S542 | Phosphorylation | Uniprot |
翻译修饰 - P19525 作为激酶
Substrate | Site | Source |
---|---|---|
P04637-1 (TP53) | S392 | Uniprot |
P05198 (EIF2S1) | S49 | Uniprot |
P05198 (EIF2S1) | S52 | Uniprot |
P06493 (CDK1) | Y4 | Uniprot |
P10636-8 (MAPT) | S262 | Uniprot |
P10636-8 (MAPT) | S356 | Uniprot |
P19525 (EIF2AK2) | S83 | Uniprot |
P19525 (EIF2AK2) | T88 | Uniprot |
P19525 (EIF2AK2) | T89 | Uniprot |
P19525 (EIF2AK2) | T90 | Uniprot |
P19525 (EIF2AK2) | Y101 | Uniprot |
P19525 (EIF2AK2) | Y162 | Uniprot |
P19525 (EIF2AK2) | S242 | Uniprot |
P19525 (EIF2AK2) | T255 | Uniprot |
P19525 (EIF2AK2) | T258 | Uniprot |
P19525 (EIF2AK2) | Y293 | Uniprot |
P19525 (EIF2AK2) | T446 | Uniprot |
P19525 (EIF2AK2) | T451 | Uniprot |
P25963 (NFKBIA) | S32 | Uniprot |
P42224 (STAT1) | S727 | Uniprot |
Q15172 (PPP2R5A) | S28 | Uniprot |
研究背景
IFN-induced dsRNA-dependent serine/threonine-protein kinase which plays a key role in the innate immune response to viral infection and is also involved in the regulation of signal transduction, apoptosis, cell proliferation and differentiation. Exerts its antiviral activity on a wide range of DNA and RNA viruses including hepatitis C virus (HCV), hepatitis B virus (HBV), measles virus (MV) and herpes simplex virus 1 (HHV-1). Inhibits viral replication via phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (EIF2S1), this phosphorylation impairs the recycling of EIF2S1 between successive rounds of initiation leading to inhibition of translation which eventually results in shutdown of cellular and viral protein synthesis. Also phosphorylates other substrates including p53/TP53, PPP2R5A, DHX9, ILF3, IRS1 and the HHV-1 viral protein US11. In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity and phosphorylates CDK1 at 'Tyr-4' upon DNA damage, facilitating its ubiquitination and proteosomal degradation. Either as an adapter protein and/or via its kinase activity, can regulate various signaling pathways (p38 MAP kinase, NF-kappa-B and insulin signaling pathways) and transcription factors (JUN, STAT1, STAT3, IRF1, ATF3) involved in the expression of genes encoding proinflammatory cytokines and IFNs. Activates the NF-kappa-B pathway via interaction with IKBKB and TRAF family of proteins and activates the p38 MAP kinase pathway via interaction with MAP2K6. Can act as both a positive and negative regulator of the insulin signaling pathway (ISP). Negatively regulates ISP by inducing the inhibitory phosphorylation of insulin receptor substrate 1 (IRS1) at 'Ser-312' and positively regulates ISP via phosphorylation of PPP2R5A which activates FOXO1, which in turn up-regulates the expression of insulin receptor substrate 2 (IRS2). Can regulate NLRP3 inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 and NLRC4 inflammasomes. Can trigger apoptosis via FADD-mediated activation of CASP8. Plays a role in the regulation of the cytoskeleton by binding to gelsolin (GSN), sequestering the protein in an inactive conformation away from actin.
Autophosphorylated on several Ser, Thr and Tyr residues. Autophosphorylation of Thr-451 is dependent on Thr-446 and is stimulated by dsRNA binding and dimerization. Autophosphorylation apparently leads to the activation of the kinase. Tyrosine autophosphorylation is essential for efficient dsRNA-binding, dimerization, and kinase activation.
Cytoplasm. Nucleus. Cytoplasm>Perinuclear region.
Note: Nuclear localization is elevated in acute leukemia, myelodysplastic syndrome (MDS), melanoma, breast, colon, prostate and lung cancer patient samples or cell lines as well as neurocytes from advanced Creutzfeldt-Jakob disease patients.
Highly expressed in thymus, spleen and bone marrow compared to non-hematopoietic tissues such as small intestine, liver, or kidney tissues. Colocalizes with GSK3B and TAU in the Alzheimer disease (AD) brain. Elevated levels seen in breast and colon carcinomas, and which correlates with tumor progression and invasiveness or risk of progression.
Homodimer. Interacts with STRBP (By similarity). Interacts with DNAJC3. Forms a complex with FANCA, FANCC, FANCG and HSP70. Interacts with ADAR/ADAR1. Interacts with IRS1 (By similarity). The inactive form interacts with NCK1 and GSN. Interacts (via the kinase catalytic domain) with STAT3 (via SH2 domain), TRAF2 (C-terminus), TRAF5 (C-terminus) and TRAF6 (C-terminus). Interacts with MAP2K6, IKBKB/IKKB, NPM1, TARBP2, NLRP1, NLRP3, NLRC4 and AIM2. Interacts (via DRBM 1 domain) with DUS2L (via DRBM domain). Interacts with DHX9 (via N-terminus) and this interaction is dependent upon activation of the kinase.
(Microbial infection) Interacts with human herpes simplex virus 1 (HHV-1) protein US11 in an RNA-dependent manner.
(Microbial infection) The inactive form interacts with Toscana virus (TOS) NSS.
(Microbial infection) Interacts with herpes virus 8 protein v-IRF2; this interaction inhibits EIF2AK2 activation.
(Microbial infection) Interacts with vaccinia protein E3.
Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. GCN2 subfamily.
研究领域
· Cellular Processes > Cell growth and death > Necroptosis. (View pathway)
· Genetic Information Processing > Folding, sorting and degradation > Protein processing in endoplasmic reticulum. (View pathway)
· Human Diseases > Infectious diseases: Viral > Hepatitis C.
· Human Diseases > Infectious diseases: Viral > Measles.
· Human Diseases > Infectious diseases: Viral > Influenza A.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.
· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.
· Human Diseases > Cancers: Overview > Viral carcinogenesis.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.